RankingsPricing
  1. JP-listed companies
  2. Fuso Pharmaceutical Industries,Ltd.
  3. Financials
  4. Revenue

Fuso Pharmaceutical Industries,Ltd.【JP:4538】

Market cap
¥22.4B
P/E ratio
8.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 202560,563+9.31%
Mar 31, 202455,407+8.61%
Mar 31, 202351,015+2.79%
Mar 31, 202249,632+0.77%
Mar 31, 202149,251+5.01%
Mar 31, 202046,902+1.80%
Mar 31, 201946,074+0.38%
Mar 31, 201845,900-1.89%
Mar 31, 201746,782+2.25%
Mar 31, 201645,752-2.74%
Mar 31, 201547,042-4.19%
Mar 31, 201449,098+1.06%
Mar 31, 201348,581+9.61%
Mar 31, 201244,320

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)